- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
短期的强势行情可能结束，投资者及时短线卖出、离场观望为宜。
- 中期趋势：
-
- 长期趋势：
已有33家主力机构披露2024-06-30报告期持股数据，持仓量总计1524.13万股，占流通A股16.48%
- 波段诊断：
-
技术面诊股
诊断结果：4.6技术面打败了96%的股票
技术面评分前10的股票
近期的平均成本为47.75元。
平均成本
近期的平均成本为47.75元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"47.75","date":1732181034,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑赢大盘，明显跑赢行业平均水平。
[{"date":"2024.11.22","stock":"-8.97","trade":null,"ind":"-3.06"},{"date":"2024.11.21","stock":"-0.08","trade":null,"ind":"0.07"},{"date":"2024.11.20","stock":"20.01","trade":null,"ind":"0.66"},{"date":"2024.11.19","stock":"19.13","trade":null,"ind":"0.67"},{"date":"2024.11.18","stock":"10.25","trade":null,"ind":"-0.21"},{"date":"2024.11.15","stock":"6.38","trade":null,"ind":"-1.45"},{"date":"2024.11.14","stock":"-3.69","trade":null,"ind":"-1.73"},{"date":"2024.11.13","stock":"-0.85","trade":null,"ind":"0.51"},{"date":"2024.11.12","stock":"0.51","trade":null,"ind":"-1.39"},{"date":"2024.11.11","stock":"2.50","trade":null,"ind":"0.51"},{"date":"2024.11.08","stock":"-1.41","trade":null,"ind":"-0.53"},{"date":"2024.11.07","stock":"0.68","trade":null,"ind":"2.57"},{"date":"2024.11.06","stock":"-0.99","trade":null,"ind":"-0.09"},{"date":"2024.11.05","stock":"0.61","trade":null,"ind":"2.32"},{"date":"2024.11.04","stock":"4.40","trade":null,"ind":"1.17"},{"date":"2024.11.01","stock":"-6.14","trade":null,"ind":"-0.24"},{"date":"2024.10.31","stock":"6.54","trade":null,"ind":"0.42"},{"date":"2024.10.30","stock":"1.40","trade":null,"ind":"-0.61"},{"date":"2024.10.29","stock":"-3.67","trade":null,"ind":"-1.08"},{"date":"2024.10.28","stock":"-1.01","trade":null,"ind":"0.68"},{"date":"2024.10.25","stock":"5.73","trade":null,"ind":"0.59"}]
热景生物,上证指数,医疗器械指数
压力支撑
该股压力位为47.67元，支撑位为43.20元。
[{"text":"\u538b\u529b\u4f4d","value":"47.67","date":1732204800,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"43.20","date":1732204800,"color":"0x0b52a1"}]
多空趋势
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：6.2资金面打败了93%的股票
主力控盘前10的股票
行业资金
医疗器械行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：11月22日 17:53
| 机构今日流向(万元) | -2656.76 | 机构5日流向(万元) | -2575.39 |
| 机构10日流向(万元) | -7329.81 | 机构20日流向(万元) | -12778.38 |
机构持仓
2024-06-30 与 2023-12-31 相比，主力机构持仓量增加41.10万股，其中基金净增仓4家，主力净减仓32家，请投资者中长期谨慎为宜。
截止2024-06-30，共33家主力机构（一般法人3家，基金30家），持仓量总计1524.13万股，占流通A股16.48%
其中，基金持仓与2023-12-31相比：
增仓：11家 ，增持 47.29万股
减仓：7家 ，减持 14.15万股
新出现在主力名单中：9家 ，持有98.78万股
从主力名单中消失：41家 ，原持有380.12万股
其中，基金持仓与2023-12-31相比：
增仓：11家 ，增持 47.29万股
减仓：7家 ，减持 14.15万股
新出现在主力名单中：9家 ，持有98.78万股
从主力名单中消失：41家 ，原持有380.12万股
消息面诊股
诊断结果：5.5消息面打败了80%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 热景生物：11月21日获融资买入9231.86万元
2024-11-22 - 热景生物：获16项境外资质认证
2024-11-21 - 热景生物11月21日主力大幅流出
2024-11-21 - 热景生物：11月20日获融资买入1.09亿元，占当
2024-11-21 - 重要公告速递：汇金科技股份转让事项淄博国投尚未取得
2024-11-21 - 热景生物：公司拟回购不超过222.22万股公司股份
2024-11-21 - 热景生物：拟以5800万元-1亿元回购股份
2024-11-20 - 热景生物11月20日主力大幅流入
2024-11-20 - 涨停雷达：回购+体外诊断+阿尔兹海默 热景生物触及
2024-11-20 - 热景生物：11月19日获融资买入7074.97万元
2024-11-20
消息列表
| 一般消息 | 募资投向 | 2024-09-26 | |
| 一般消息 | 资产重组 | 公司股权转让 | 2024-09-13 |
| 一般消息 | 分红转增 | 不分配不转增 | 2024-08-30 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2024-06-30 |
| 一般消息 | 募资投向 | 公司出售资产 | 2024-06-19 |
| 一般消息 | 重大事项 | 关联交易 | 2024-06-19 |
| 一般消息 | 高管变动 | 因任职子公司热景(廊坊)生物技术有... | 2024-05-13 |
| 一般消息 | 股东大会 | 年度股东大会 | 2024-04-30 |
| 利好 | 分红转增 | 10派2元(含税) | 2024-04-30 |
| 一般消息 | 重大事项 | 关联交易 | 2024-04-30 |
| 一般消息 | 募资投向 | 公司购买资产 | 2024-04-16 |
| 一般消息 | 重大事项 | 关联交易 | 2024-04-16 |
| 一般消息 | 募资投向 | 公司出售资产 | 2024-02-06 |
| 一般消息 | 重大事项 | 关联交易 | 2024-02-06 |
| 一般消息 | 高管变动 | 因工作重心调整 | 2024-02-02 |
| 重大利空 | 业绩预告 | 业绩大幅下降 | 2024-01-31 |
| 一般消息 | 高管变动 | 因工作重心调整 | 2024-01-16 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2023-12-31 |
| 一般消息 | 高管变动 | 不再认定为核心技术人员 | 2023-12-26 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 3条 | 0条 | 3条 |
| 利空 | 1条 | 1条 | 0条 |
行业面诊股
诊断结果：0.0行业面打败了10%的股票
医疗器械行业最新资金流向
-
行业走势
[{"date":"2024.11.22","price":"-3.06","value":null},{"date":"2024.11.21","price":"0.07","value":null},{"date":"2024.11.20","price":"0.66","value":null},{"date":"2024.11.19","price":"0.67","value":null},{"date":"2024.11.18","price":"-0.21","value":null},{"date":"2024.11.15","price":"-1.45","value":null},{"date":"2024.11.14","price":"-1.73","value":null},{"date":"2024.11.13","price":"0.51","value":null},{"date":"2024.11.12","price":"-1.39","value":null},{"date":"2024.11.11","price":"0.51","value":null},{"date":"2024.11.08","price":"-0.53","value":null},{"date":"2024.11.07","price":"2.57","value":null},{"date":"2024.11.06","price":"-0.09","value":null},{"date":"2024.11.05","price":"2.32","value":null},{"date":"2024.11.04","price":"1.17","value":null},{"date":"2024.11.01","price":"-0.24","value":null},{"date":"2024.10.31","price":"0.42","value":null},{"date":"2024.10.30","price":"-0.61","value":null},{"date":"2024.10.29","price":"-1.08","value":null},{"date":"2024.10.28","price":"0.68","value":null},{"date":"2024.10.25","price":"0.59","value":"-357279036.44"}]
上证指数,医疗器械行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 浩欧博 | 405.35% | 11.37% | 5.0分 |
| 2 | 热景生物 | 49.74% | 43.37% | 4.5分 |
| 3 | 东方海洋 | 25.00% | 9.32% | 3.2分 |
| 4 | 仁度生物 | 20.44% | -3.87% | 4.2分 |
| 5 | 国发股份 | 18.59% | 3.28% | 4.0分 |
| 6 | 奥美医疗 | 18.31% | 21.01% | 4.3分 |
| 8 | 东星医疗 | 16.21% | 4.84% | 4.3分 |
| 10 | 采纳股份 | 14.77% | 7.67% | 3.7分 |
| 12 | 中红医疗 | 11.25% | 11.16% | 4.1分 |
| 14 | 赛科希德 | 9.59% | -0.04% | 4.9分 |
| 16 | 凯利泰 | 8.04% | -0.17% | 4.2分 |
| 18 | 理邦仪器 | 6.10% | 10.22% | 4.7分 |
| 20 | 天智航 | 5.05% | -0.39% | 4.2分 |
| 22 | 康德莱 | 4.78% | -1.32% | 4.6分 |
| 24 | 康拓医疗 | 3.86% | -1.23% | 4.9分 |
| 26 | 尚荣医疗 | 3.53% | 1.57% | 4.3分 |
| 28 | 港通医疗 | 3.17% | 1.15% | 4.1分 |
| 30 | 博拓生物 | 2.55% | 2.10% | 4.6分 |
| 32 | 黄山胶囊 | 2.42% | -0.63% | 3.8分 |
| 34 | 凯普生物 | 2.35% | 4.81% | 3.5分 |
| 36 | 伟思医疗 | 2.27% | -4.89% | 4.3分 |
| 38 | 明德生物 | 1.82% | 0.80% | 3.9分 |
| 40 | 迈普医学 | 1.30% | -3.41% | 4.2分 |
| 42 | 九安医疗 | 1.06% | -1.03% | 4.4分 |
| 44 | 鱼跃医疗 | 0.77% | -3.83% | 4.6分 |
| 46 | 海泰新光 | 0.42% | -2.25% | 4.4分 |
| 48 | 维力医疗 | 0.23% | -2.03% | 4.9分 |
| 50 | 科美诊断 | 0.00% | -1.83% | 4.5分 |
| 52 | 三鑫医疗 | -0.25% | -0.75% | 4.7分 |
| 54 | 安图生物 | -1.12% | -3.32% | 4.8分 |
| 56 | 安杰思 | -1.35% | -1.21% | 4.7分 |
| 58 | 南微医学 | -1.85% | -3.64% | 4.6分 |
| 60 | 振德医疗 | -2.04% | -2.50% | 4.2分 |
| 62 | 九强生物 | -2.17% | -3.31% | 3.6分 |
| 64 | 易瑞生物 | -2.42% | -1.28% | 3.8分 |
| 66 | 迈克生物 | -2.54% | -2.54% | 3.6分 |
| 68 | 天臣医疗 | -2.89% | -1.86% | 4.5分 |
| 70 | 奥精医疗 | -3.21% | -1.43% | 3.6分 |
| 72 | 圣湘生物 | -3.48% | -0.27% | 4.2分 |
| 74 | 艾德生物 | -3.99% | -1.70% | 4.1分 |
| 76 | 硕世生物 | -4.06% | -6.09% | 3.6分 |
| 78 | 东方生物 | -4.88% | 3.01% | 3.9分 |
| 80 | 新华医疗 | -5.12% | -3.33% | 4.4分 |
| 82 | 欧普康视 | -5.35% | -5.60% | 3.9分 |
| 84 | 乐普医疗 | -5.48% | -3.18% | 3.8分 |
| 86 | 华兰股份 | -5.62% | -4.22% | 3.6分 |
| 88 | 英诺特 | -5.78% | -2.13% | 4.8分 |
| 90 | 迪瑞医疗 | -5.96% | -4.29% | 3.9分 |
| 92 | 万孚生物 | -6.14% | -2.61% | 3.8分 |
| 94 | 春立医疗 | -6.34% | -4.02% | 4.2分 |
| 96 | 东富龙 | -6.90% | -4.71% | 3.7分 |
| 98 | 健帆生物 | -7.03% | -4.54% | 4.2分 |
| 100 | 正海生物 | -7.45% | -5.43% | 3.6分 |
| 102 | 惠泰医疗 | -8.22% | 3.60% | 5.4分 |
| 104 | 华大智造 | -8.85% | -0.75% | 3.9分 |
| 106 | 怡和嘉业 | -10.19% | -2.67% | 3.8分 |
| 108 | 爱迪特 | -10.60% | -5.35% | 3.8分 |
| 110 | 威高骨科 | -10.81% | -5.33% | 4.4分 |
| 112 | 山东药玻 | -11.25% | -3.98% | 4.6分 |
| 114 | 亚辉龙 | -11.90% | -4.43% | 4.5分 |
| 116 | 新产业 | -12.48% | -8.72% | 3.8分 |
| 118 | 爱博医疗 | -13.45% | -8.70% | 4.3分 |
| 120 | 美好医疗 | -14.44% | -4.40% | 3.7分 |
| 122 | 康为世纪 | -16.90% | -5.00% | 3.2分 |
| 124 | - | -57.89% | -14.16% | 分 |
行业评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 暂无相关评级 |
更多>>行业资讯
- 2012-02-17青岛：加快向“世界强港”转型新增万吨级泊位24个
- 2012-02-17江苏港口发展“四稳四进”
- 2012-02-17今年河北省重点打造综合性港口群
- 2012-02-16招商轮船：非公开发行A股股票申请获得中国证券监督管理委员会核准
- 2012-02-16泉州市今年将冲刺“亿吨大港”
- 2012-02-16大连市集装箱运输生产“逆市飘红”
- 2012-02-16江苏港口发展“四稳四进”
- 2012-02-16连云港港：绿色生态大港正向我们走来
- 2012-02-15靖江今年港口建设预投28亿元 完成港口货物吞吐量8000万吨
- 2012-02-15舟山“大港口”建设撬动群岛新区大盘
基本面诊股
[ 截止日期：2024-09-30 ]公司经营
盈利能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 109/246 ， 69/246。
[{"date":"2024-09-30","value":"-1.23","vol":"4.75"},{"date":"2024-06-30","value":"-1.32","vol":"3.52"},{"date":"2024-03-31","value":"0.15","vol":"1.68"},{"date":"2023-12-31","value":"0.82","vol":"12.42"},{"date":"2023-09-30","value":"1.61","vol":"5.68"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
-1.23 | -1.32 | 0.15 | 0.82 | 1.61 |
| 行业(%) | 4.75 | 3.52 | 1.68 | 12.42 | 5.68 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"52.44","vol":"53.32"},{"date":"2024-06-30","value":"49.98","vol":"53.55"},{"date":"2024-03-31","value":"59.04","vol":"53.24"},{"date":"2023-12-31","value":"56.95","vol":"53.43"},{"date":"2023-09-30","value":"64.10","vol":"53.80"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
52.44 | 49.98 | 59.04 | 56.95 | 64.10 |
| 行业(%) | 53.32 | 53.55 | 53.24 | 53.43 | 53.80 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 79/246 ， 117/246。
[{"date":"2024-09-30","value":"-5.10","vol":"1.30"},{"date":"2024-06-30","value":"-18.96","vol":"0.82"},{"date":"2024-03-31","value":"-42.78","vol":"-0.80"},{"date":"2023-12-31","value":"-84.78","vol":"-6.80"},{"date":"2023-09-30","value":"-86.48","vol":"-5.88"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-5.10 | -18.96 | -42.78 | -84.78 | -86.48 |
| 行业(%) | 1.30 | 0.82 | -0.80 | -6.80 | -5.88 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"-174.73","vol":"-19.51"},{"date":"2024-06-30","value":"-151.28","vol":"10.41"},{"date":"2024-03-31","value":"-91.42","vol":"-14.99"},{"date":"2023-12-31","value":"-97.10","vol":"-23.60"},{"date":"2023-09-30","value":"-95.06","vol":"-0.28"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-174.73 | -151.28 | -91.42 | -97.10 | -95.06 |
| 行业(%) | -19.51 | 10.41 | -14.99 | -23.60 | -0.28 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 111/246 ， 58/246。
[{"date":"2024-09-30","value":"0.11","vol":"0.26"},{"date":"2024-06-30","value":"0.07","vol":"0.18"},{"date":"2024-03-31","value":"0.03","vol":"0.09"},{"date":"2023-12-31","value":"0.15","vol":"0.37"},{"date":"2023-09-30","value":"0.11","vol":"0.27"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.11 | 0.07 | 0.03 | 0.15 | 0.11 |
| 行业(次) | 0.26 | 0.18 | 0.09 | 0.37 | 0.27 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"1.47","vol":"1.70"},{"date":"2024-06-30","value":"0.98","vol":"1.14"},{"date":"2024-03-31","value":"0.37","vol":"0.55"},{"date":"2023-12-31","value":"1.61","vol":"2.30"},{"date":"2023-09-30","value":"1.01","vol":"1.61"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
1.47 | 0.98 | 0.37 | 1.61 | 1.01 |
| 行业(次) | 1.70 | 1.14 | 0.55 | 2.30 | 1.61 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2024-09-30","value":"-4.18","vol":"15.39"},{"date":"2024-06-30","value":"7.66","vol":"12.54"},{"date":"2024-03-31","value":"-12.06","vol":"2.18"},{"date":"2023-12-31","value":"222.87","vol":"38.60"},{"date":"2023-09-30","value":"-151.96","vol":"18.30"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | -4.18 | 7.66 | -12.06 | 222.87 | -151.96 |
| 行业 | 15.39 | 12.54 | 2.18 | 38.60 | 18.30 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"","vol":"0.00"},{"date":"2024-06-30","value":"0.67","vol":"2.34"},{"date":"2024-03-31","value":"","vol":"0.07"},{"date":"2023-12-31","value":"5.28","vol":"2.90"},{"date":"2023-09-30","value":"","vol":"0.00"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.67 | - | 5.28 | - |
| 行业 | 0.00 | 2.34 | 0.07 | 2.90 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 102/246 ， 72/246。
[{"date":"2024-09-30","value":"9.85","vol":"5.99"},{"date":"2024-06-30","value":"6.88","vol":"6.01"},{"date":"2024-03-31","value":"6.20","vol":"6.60"},{"date":"2023-12-31","value":"4.48","vol":"5.84"},{"date":"2023-09-30","value":"5.51","vol":"6.82"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
9.85 | 6.88 | 6.20 | 4.48 | 5.51 |
| 行业 | 5.99 | 6.01 | 6.60 | 5.84 | 6.82 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"4.26","vol":"4.83"},{"date":"2024-06-30","value":"3.29","vol":"4.95"},{"date":"2024-03-31","value":"2.87","vol":"5.51"},{"date":"2023-12-31","value":"3.18","vol":"4.84"},{"date":"2023-09-30","value":"3.49","vol":"5.72"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
4.26 | 3.29 | 2.87 | 3.18 | 3.49 |
| 行业 | 4.83 | 4.95 | 5.51 | 4.84 | 5.72 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 122/246 ， 121/246。
[{"date":"2024-09-30","value":"4.42","vol":"21.18"},{"date":"2024-06-30","value":"4.94","vol":"21.17"},{"date":"2024-03-31","value":"5.89","vol":"20.66"},{"date":"2023-12-31","value":"5.69","vol":"21.24"},{"date":"2023-09-30","value":"5.57","vol":"21.28"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
4.42 | 4.94 | 5.89 | 5.69 | 5.57 |
| 行业(%) | 21.18 | 21.17 | 20.66 | 21.24 | 21.28 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"0.05","vol":"0.38"},{"date":"2024-06-30","value":"0.05","vol":"0.37"},{"date":"2024-03-31","value":"0.06","vol":"0.36"},{"date":"2023-12-31","value":"0.06","vol":"0.37"},{"date":"2023-09-30","value":"0.06","vol":"0.36"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.05 | 0.05 | 0.06 | 0.06 | 0.06 |
| 行业(%) | 0.38 | 0.37 | 0.36 | 0.37 | 0.36 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2024年的收益，请投资者后续关注。
[{"date":"2020","yellowRectValue":"1.12","blueLineValue":"","type":""},{"date":"2021","yellowRectValue":"21.86","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"9.45","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"0.27","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]